Novo Nordisk Other Share Holders Equity 2010-2024 | NVO

Novo Nordisk other share holders equity for the quarter ending June 30, 2024 was $-0.011B, a 103.78% decline year-over-year.

  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.
  • Novo Nordisk other share holders equity for 2022 was $0.347B, a 227.17% decline from 2021.
  • Novo Nordisk other share holders equity for 2021 was $-0.273B, a 95.39% increase from 2020.

Novo Nordisk Other Share Holders Equity 2010-2024 | NVO

  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.
  • Novo Nordisk other share holders equity for 2022 was $0.347B, a 227.17% decline from 2021.
  • Novo Nordisk other share holders equity for 2021 was $-0.273B, a 95.39% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B